Navigation Links
Bard Visilex® Mesh

ProductsBard Visilex® Mesh
Company Davol, Inc.
Item Bard Visilex® Mesh
Features 
  • The first polypropylene mesh specifically designed for laparoscopic hernia repair
  • Reinforced edge can be easily grasped and manipulated with standard laparoscopic instruments
  • Constructed of monofilament polypropylene
  • Visilex Mesh Comes with One Other Significant Advantage: Our Monofilament Polypropylene
  • Description Bard Visilex mesh is the first polypropylene mesh specifically designed for laparoscopic hernia repair. Visilex mesh directly addresses the critical issues associated with laparoscopic procedures. More specifically, it delivers maximum visibility, enhanced maneuverability and retains a flat profile after insertion through the trocar. Visilex mesh is the culmination of input and insight from laparoscopic surgeons. With a myriad of clinical benefits, it will change the way you look at laparoscopic hernia repair. The Visilex reinforced edge can be easily grasped and manipulated with standard laparoscopic instruments, eliminating the need for additional instruments to assist in mesh positioning. The Visilex reinforced edge also helps the mesh easily return to its original flat shape after simple insertion through the trocar. During placement, the mesh maintains flexibility necessary to conform to the anatomy - without ever losing the integrity of its shape. Visilex mesh is the first laparoscopic mesh to offer the clinical advantage of a patented reinforced edge. Visilex Mesh Comes with One Other Significant Advantage: Our Monofilament Polypropylene. Visilex mesh is constructed with monofilament polypropylene for which Bard is famous. This proven material is inert in the presence of infection, will not harbor bacteria, and promotes tissue ingrowth1-3. Furthermore, the unique knit construction of Visilex mesh will not unravel. Not surprisingly, this monofilament polypropylene continues to be the material of choice for lasting hernia repair.
    Info Davol, Inc.
    Customer Service: (800) 556-6756
    Web site: http://www.davol.com/

    Related medicine products :

    1. Sinskey Hook Modified
    2. Modified Mayfield Skull Clamp
    3. Modified Freer Periosteal Elevator
    4. Modified Freer Periosteal Elevator #163
    5. Disposable Two-Part Wilkov Modified Needle
    6. Disposable Two-Part Cook Modified Needles
    7. Spencer Modified Biliary Wire Guides
    8. Bunnell Mini-Modified Safety Finger Pin
    9. Gamma GT (Modified IFCC)
    10. Acid Fast Stain, Partial or Modified (for Nocardia sp.)
    11. Parasitology Stain by Modified Acid-Fast
    Other Medicine News:Health News:Patient-centered approach to capturing data from cancer patients improves care and research 2Health News:Gene signature may predict patient response to therapy for gastrointestinal stromal tumors 2Health News:Ginger Eases Nausea From Chemo 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 3Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 2Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 3Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 4Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 5Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 6Health News:MedServe to be Acquired by Stericycle for $185 Million 2Health News:MedServe to be Acquired by Stericycle for $185 Million 3
    Breaking Medicine Technology:European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 1HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 2Niusule Expands Geographic Footprint in China 14900 1Niusule Expands Geographic Footprint in China 14900 2Niusule Expands Geographic Footprint in China 14900 3Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 1Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 2Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 3Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 4Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 5Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 6